TY - JOUR
T1 - Clusters of smooth endoplasmic reticulum are absent in oocytes from unstimulated women
AU - Nikiforov, Dmitry
AU - Cadenas, Jesús
AU - Mamsen, Linn Salto
AU - Wakimoto, Yu
AU - Kristensen, Stine Gry
AU - Pors, Susanne Elisabeth
AU - Andersen, Claus Yding
N1 - Copyright © 2021 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
PY - 2021/7
Y1 - 2021/7
N2 - RESEARCH QUESTION: What is the frequency of morphological dysmorphisms in immature human oocytes collected ex vivo from small antral follicles and matured in vitro?DESIGN: Human ovaries (n = 56) were excised for ovarian tissue cryopreservation (OTC). None of the patients had received exogenous gonadotrophins prior to the procedure. Immature oocytes released from small antral follicles were collected in connection with isolation of the cortex for OTC. The oocytes' maturation stage and the morphological characteristics of the cytoplasm, zona pellucida, perivitelline space and first polar body were assessed after in-vitro maturation (IVM).RESULTS: A total of 1649 immature oocytes were collected: 30% of oocytes matured to the metaphase II (MII) stage after IVM, while metaphase I (MI), germinal vesicle and degenerated oocytes accounted for 20%, 24% and 26%, respectively. The percentages of oocytes without any dysmorphisms were 53%, 92%, and 97% for the MII, MI and germinal vesicle stage oocytes, respectively. The most frequently observed dysmorphisms among the MII oocytes were first polar body fragmentation (22%), homogeneously distributed cytoplasmic granularity (16%) and an enlarged perivitelline space (14%). Interestingly, none of the oocytes at any stage had clusters of smooth endoplasmic reticulum (SER).CONCLUSIONS: Morphological dysmorphisms are present among in-vitro-matured oocytes at all maturation stages. The incidence of dysmorphisms increases as maturation progresses. The most frequent dysmorphism among MII oocytes after IVM was fragmentation of the first polar body. Clusters of SER were not observed in oocytes from unstimulated patients.
AB - RESEARCH QUESTION: What is the frequency of morphological dysmorphisms in immature human oocytes collected ex vivo from small antral follicles and matured in vitro?DESIGN: Human ovaries (n = 56) were excised for ovarian tissue cryopreservation (OTC). None of the patients had received exogenous gonadotrophins prior to the procedure. Immature oocytes released from small antral follicles were collected in connection with isolation of the cortex for OTC. The oocytes' maturation stage and the morphological characteristics of the cytoplasm, zona pellucida, perivitelline space and first polar body were assessed after in-vitro maturation (IVM).RESULTS: A total of 1649 immature oocytes were collected: 30% of oocytes matured to the metaphase II (MII) stage after IVM, while metaphase I (MI), germinal vesicle and degenerated oocytes accounted for 20%, 24% and 26%, respectively. The percentages of oocytes without any dysmorphisms were 53%, 92%, and 97% for the MII, MI and germinal vesicle stage oocytes, respectively. The most frequently observed dysmorphisms among the MII oocytes were first polar body fragmentation (22%), homogeneously distributed cytoplasmic granularity (16%) and an enlarged perivitelline space (14%). Interestingly, none of the oocytes at any stage had clusters of smooth endoplasmic reticulum (SER).CONCLUSIONS: Morphological dysmorphisms are present among in-vitro-matured oocytes at all maturation stages. The incidence of dysmorphisms increases as maturation progresses. The most frequent dysmorphism among MII oocytes after IVM was fragmentation of the first polar body. Clusters of SER were not observed in oocytes from unstimulated patients.
KW - Adolescent
KW - Adult
KW - Endoplasmic Reticulum, Smooth
KW - Female
KW - Humans
KW - In Vitro Oocyte Maturation Techniques
KW - Oocytes/pathology
KW - Young Adult
KW - Smooth endoplasmic reticulum
KW - Oocyte dysmorphisms
KW - Oocyte morphology
KW - Human oocytes
KW - In-vitro maturation
UR - http://www.scopus.com/inward/record.url?scp=85106236611&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2021.03.007
DO - 10.1016/j.rbmo.2021.03.007
M3 - Journal article
C2 - 34006484
SN - 1472-6483
VL - 43
SP - 26
EP - 32
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 1
ER -